Sign in
4

Changes in Ownership

TREACE MEDICAL CONCEPTS, INC. Filed Acc 0000950170-25-042291

Chief Innovation Officer sold 50,000 shares at $7.97 ($398,460)

  • Chief Innovation Officer acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Scanlan Sean F. · Chief Innovation Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-17 Exercise or conversion : show line 1 in the form 10b5-1 +50,000 $1.05 $52,500 414,081 D
2025-03-17 Sale : show line 2 in the form 10b5-1 −50,000 $7.97 $398,460 364,081 D
Open-market sales · 50,000 sh · avg $7.97 · $398,460

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-17 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −50,000 16,875 D
Loading xslF345X05/ownership.xml…